ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

PIM1-mediated signalling as a therapeutic target in breast cancer: repurposing venetoclax for targeted inhibition.

Sailayee Choudhury et al.PubMed ↗Publisher ↗

No numbers read from the abstract.